ACB
Aurora CannabisCNasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-06-02
Current thesis
Re-rating to the analyst high driven by sustained margin expansion, successful international launches, and better-than-expected revenue mix shift toward higher-margin products.
Posture
Mixed
Lead driver
Sentiment
What changed
Sentiment remains the lead driver in the composite, 7D delta 0.0.
What can break
Analyst downgrades or equity raises increasing dilution
Momentum
24
Value
41
Sentiment
100
Setup hits (3d)
0 · Net Neutral
AI TargetsBase $6.03 · Bull $10.50 · Bear $4.25
Data freshness
Prices
As of 2026-06-02
Fundamentals
As of 2026-06-01 • Vendor: Data Vendor v1
Scores
As of 2026-06-02 • Model: HYBRID_IC_RP
AI Memo
As of 2026-01-26 • Model: RankAlpha Sentiment AI
Investment thesisAs of 2026-06-02
Investment thesis
As of 2026-06-02
Supporting evidence
What
Grade C · Mixed
Confidence Medium · Net Neutral
Target $5.57
Why
Momentum24 · Δ7d +4.5
Value41 · Δ7d +0.1
Sentiment100 · Δ7d 0.0
So what
Balanced signals (Net Neutral). Wait for confirmation before sizing up.
Lead driver: Sentiment · See AI snapshot
Momentum
24
34% active weight
Current posture
7d trendImproving
Δ7d
+4.5
Δ21d
+12.5
Value
41
32% active weight
Current posture
7d trendFlat
Δ7d
+0.1
Δ21d
+0.2
Sentiment
100
33% active weight
Current posture
7d trendFlat
Δ7d
0.0
Δ21d
0.0
Why this grade
Composite grade C. Momentum 24.3 / Value 41.1 / Sentiment 100.0
Fundamentals (TTM)As of 2026-06-01
Fundamentals (TTM)
As of 2026-06-01
Market Cap
$206.15M
Beta
1.32
Shares Out
56.22M
P/E (TTM) · Derived
-0.1
P/S (TTM)
0.90
P/FCF (TTM) · Derived
-15.65
Rev YoY
+11.4%
EPS YoY
-2218.2%
Gross Margin
+1.7%
Op Margin
-17.8%
Net Debt
-
Current Ratio
3.41
As of 2026-06-02 • Updated nightlySource: Internal modelMethodology